Last edition
News about " investigational drug candidate"
AlzeCure Receives USD 10 Million Upfront Payment from Eli Lilly for Alzheimer's Drug Programme
AlzeCure Pharma has received a USD 10 million upfront payment from Eli Lilly, completing the initial transaction for global rights to its Alzstatin Alzheimer's programme and ACD680.
Investigational Drug Candidate | 20/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members